Page last updated: 2024-10-24

calmidazolium and Thymoma

calmidazolium has been researched along with Thymoma in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calviello, G1
Bossi, D1
Cittadini, A1

Other Studies

1 other study available for calmidazolium and Thymoma

ArticleYear
Further observations on the effect of calcium ionophores on ascites tumor cells.
    Archives of biochemistry and biophysics, 1987, Nov-15, Volume: 259, Issue:1

    Topics: Animals; Calcium; Ethers; Glycolysis; Imidazoles; In Vitro Techniques; Iodoacetates; Iodoacetic Acid

1987